{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:14:11Z","timestamp":1794064451353,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:00:00Z","timestamp":1758412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.euo.2025.09.012","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:24:17Z","timestamp":1760073857000},"page":"1598-1606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Impact of Kidney, Liver, and Immune Function on Circulating Tumor DNA Detection in Muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"8","author":[{"given":"Deema","family":"Radif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sia Viborg","family":"Lindskrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Birkenkamp-Demtr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Bjerggaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Agerb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-9851","authenticated-orcid":false,"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.09.012_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.09.012_b0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.09.012_b0015","unstructured":"Gupta JBM. Neoadjuvant therapy for localized muscle-invasive urothelial carcinoma of the bladder. UpToDate. https:\/\/www.uptodate.com\/contents\/neoadjuvant-therapy-for-localized-muscle-invasive-urothelial-carcinoma-of-the-bladder."},{"key":"10.1016\/j.euo.2025.09.012_b0020","doi-asserted-by":"crossref","DOI":"10.1177\/11769343211049270","article-title":"Exploration of prognostic biomarkers of muscle-invasive bladder cancer (MIBC) by bioinformatics","volume":"17","author":"Xu","year":"2021","journal-title":"Evol Bioinform Online"},{"key":"10.1016\/j.euo.2025.09.012_b0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.euo.2025.09.012_b0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euo.2024.07.001","article-title":"Association of tumor-informed circulating tumor DNA detectability before and after radical cystectomy with disease-free survival in patients with bladder cancer","volume":"8","author":"Sfakianos","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.09.012_b0035","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1158\/1078-0432.CCR-23-1860","article-title":"Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up","volume":"29","author":"Lindskrog","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2025.09.012_b0040","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.09.012_b0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.eururo.2024.05.014","article-title":"Whole-genome mutational analysis for tumor-informed detection of circulating tumor DNA in patients with urothelial carcinoma","volume":"86","author":"Nordentoft","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.09.012_b0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.euo.2025.09.012_b0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1196\/annals.1368.026","article-title":"Circulating DNA and DNase activity in human blood","volume":"1075","author":"Tamkovich","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.euo.2025.09.012_b0060","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1373\/clinchem.2016.260331","article-title":"Circulating Tumor DNA as a cancer biomarker: fact or fiction?","volume":"62","author":"Leung","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.euo.2025.09.012_b0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1196\/annals.1448.014","article-title":"Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease","volume":"1137","author":"Korabecna","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.euo.2025.09.012_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/643189","article-title":"The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels","volume":"2014","author":"McGuire","year":"2014","journal-title":"PPAR Res"},{"key":"10.1016\/j.euo.2025.09.012_b0075","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.156.3.1151","article-title":"Blood clearance kinetics and liver uptake of mononucleosomes in mice","volume":"156","author":"Gauthier","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.euo.2025.09.012_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf2341","article-title":"Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies","volume":"383","author":"Martin-Alonso","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.euo.2025.09.012_b0085","article-title":"From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers","volume":"3","author":"Watson","year":"2024","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.euo.2025.09.012_b0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41416-020-01047-5","article-title":"Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond","volume":"124","author":"Keller","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.09.012_b0095","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1078-0432.CCR-22-3250","article-title":"Cell-free urine and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle-invasive bladder cancer","volume":"29","author":"Christensen","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2025.09.012_b0100","unstructured":"ClinicalTrials.gov. Treatment of metastatic bladder cancer at the time of biochemical relapse following radical cystectomy. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04138628."},{"key":"10.1016\/j.euo.2025.09.012_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319194","article-title":"The role of renal and liver function in clinical ctDNA testing","volume":"20","author":"Koudahl Conrad","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2025.09.012_b0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/00365513.2012.662281","article-title":"Rhythmic 24-hour variations of frequently used clinical biochemical parameters in healthy young males\u2014the Bispebjerg study of diurnal variations","volume":"72","author":"Sennels","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.euo.2025.09.012_b0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.42.2.172","article-title":"Diurnal variations in serum biochemical and haematological measurements","volume":"42","author":"Pocock","year":"1989","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.euo.2025.09.012_b0120","series-title":"Physiology, albumin","author":"Moman","year":"2025"},{"key":"10.1016\/j.euo.2025.09.012_b0125","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev"},{"key":"10.1016\/j.euo.2025.09.012_b0130","first-page":"474","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.euo.2025.09.012_b0135","first-page":"1004","article-title":"Evaluation of patients with leukocytosis","volume":"92","author":"Riley","year":"2015","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.euo.2025.09.012_b0140","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.29271\/jcpsp.2022.10.1367","article-title":"Laboratory evaluation and pathological features of bone marrow metastasis in non-haematological malignancies","volume":"32","author":"Rana","year":"2022","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.euo.2025.09.012_b0145","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/pros.24231","article-title":"The role of histopathological and biochemical parameters for predicting metastatic disease on 68 Ga-PSMA-11 PET in prostate cancer","volume":"81","author":"Aydos","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.09.012_b0150","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1038\/s41598-017-08240-2","article-title":"Prognostic value of routine laboratory variables in prediction of breast cancer recurrence","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2025.09.012_b0155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fonc.2020.00146","article-title":"Prognostic value of clinical biochemistry-based indexes in nasopharyngeal carcinoma","volume":"10","author":"Zeng","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2025.09.012_b0160","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s12551-021-00849-y","article-title":"Human disease biomarker panels through systems biology","volume":"13","author":"Smith","year":"2021","journal-title":"Biophys Rev"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:39:54Z","timestamp":1778143194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125002469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2588931125002469"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.09.012","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Kidney, Liver, and Immune Function on Circulating Tumor DNA Detection in Muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}